306 related articles for article (PubMed ID: 37474966)
1. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.
Tarama CW; Soré H; Siribié M; Débé S; Kinda R; Ganou A; Nonkani WG; Tiendrebeogo F; Bantango W; Yira K; Sagnon A; Ilboudo S; Hien EY; Guelbéogo MW; Sagnon N; Traoré Y; Ménard D; Gansané A
Malar J; 2023 Jul; 22(1):213. PubMed ID: 37474966
[TBL] [Abstract][Full Text] [Related]
2. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
[TBL] [Abstract][Full Text] [Related]
3. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine.
Tahita MC; Tinto H; Erhart A; Kazienga A; Fitzhenry R; VanOvermeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; Van Geertruyden JP; D'Alessandro U
PLoS One; 2015; 10(9):e0137440. PubMed ID: 26368675
[TBL] [Abstract][Full Text] [Related]
5. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
Ruizendaal E; Tahita MC; Geskus RB; Versteeg I; Scott S; d'Alessandro U; Lompo P; Derra K; Traore-Coulibaly M; de Jong MD; Schallig HDFH; Tinto H; Mens PF
Malar J; 2017 Apr; 16(1):179. PubMed ID: 28454537
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
[TBL] [Abstract][Full Text] [Related]
7. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH
Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
11. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.
Dokomajilar C; Lankoande ZM; Dorsey G; Zongo I; Ouedraogo JB; Rosenthal PJ
Am J Trop Med Hyg; 2006 Jul; 75(1):162-5. PubMed ID: 16837725
[TBL] [Abstract][Full Text] [Related]
12. Presence of quintuple dhfr N51, C59, S108 - dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso.
Ruizendaal E; Tahita MC; Traoré-Coulibaly M; Tinto H; Schallig HDFH; Mens PF
Mol Biochem Parasitol; 2017 Oct; 217():13-15. PubMed ID: 28818675
[TBL] [Abstract][Full Text] [Related]
13. Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
Mahamar A; Sumner KM; Levitt B; Freedman B; Traore A; Barry A; Issiaka D; Dembele AB; Kanoute MB; Attaher O; Diarra BN; Sagara I; Djimde A; Duffy PE; Fried M; Taylor SM; Dicko A
Malar J; 2022 Feb; 21(1):39. PubMed ID: 35135546
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique.
Kayode AT; Ajogbasile FV; Akano K; Uwanibe JN; Oluniyi PE; Eromon PJ; Folarin OA; Sowunmi A; Wirth DF; Happi CT
Sci Rep; 2021 Jan; 11(1):471. PubMed ID: 33436791
[TBL] [Abstract][Full Text] [Related]
15. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
Dosoo DK; Bailey JA; Asante KP; Oppong FB; Niaré K; Opoku-Mensah J; Owusu-Agyei S; Greenwood B; Chandramohan D
PLoS One; 2022; 17(8):e0271489. PubMed ID: 35939419
[TBL] [Abstract][Full Text] [Related]
17. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
Berzosa P; Esteban-Cantos A; García L; González V; Navarro M; Fernández T; Romay-Barja M; Herrador Z; Rubio JM; Ncogo P; Santana-Morales M; Valladares B; Riloha M; Benito A
Malar J; 2017 Jan; 16(1):28. PubMed ID: 28086777
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin.
L'Episcopia M; Doderer-Lang C; Perrotti E; Priuli GB; Cavallari S; Guidetti C; Bernieri F; Menard D; Severini C
Acta Trop; 2023 Sep; 245():106975. PubMed ID: 37348801
[TBL] [Abstract][Full Text] [Related]
19. High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria.
Quan H; Igbasi U; Oyibo W; Omilabu S; Chen SB; Shen HM; Okolie C; Chen JH; Zhou XN
Infect Dis Poverty; 2020 Jul; 9(1):91. PubMed ID: 32653033
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Bwijo B; Kaneko A; Takechi M; Zungu IL; Moriyama Y; Lum JK; Tsukahara T; Mita T; Takahashi N; Bergqvist Y; Björkman A; Kobayakawa T
Acta Trop; 2003 Mar; 85(3):363-73. PubMed ID: 12659974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]